UCB's medicines are making a real difference to the lives of people all over the world. Some of our products are among the leaders in their field.
UCB focuses on two main therapeutic areas, CNS disorders and immunology.

UCB Canada Inc. currently markets in Canada the following medicines listed below.  Provided below are the Health Canada approved Product Monographs and Consumer Information.

Canadian laws and regulations limit the amount of information we can provide to the general public about prescription drug products. We encourage patients and consumers wishing to obtain more detailed information on our products to consult a qualified health care professional.

The product information on this web site is intended for residents of Canada only.

Please refer to Health Canada for Health Canada Advisories and Warnings.

Please contact UCB Canada Inc. Medical Information with any comments, inquiries or to report an adverse event.

Note

• Cimzia® - Registered trademark of the UCB Group of Companies
• Neupro® - Registered trademark used under license from UCB Pharma GmbH
• Vimpat® - Registered trademark used under license from Harris FRC Corporation
• Keppra® - Registered trademark of the UCB Group of Companies
• Brivlera® - Registered trademark of the UCB Group of Companies
• Bimzelx® - Registered trademark of the UCB Group of Companies

The information cited on this website is for Canada only. The medicinal products mentioned here are not approved for sale on all markets worldwide. Moreover, currently registered indications of said products may differ from country to country. Therefore, physicians should always consult local prescribing information. Patients should always consult their physician for information regarding these medicinal products.

UCB Canada Inc. is a proud member of the Health Products Stewardship Association. Don’t throw out your unused or expired health products, visit www.healthsteward.ca